18 Stocks Moving in Wednesday's Pre-Market Session Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday. Benzinga · Jun 1, 2022
77 Biggest Movers From Yesterday Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. Benzinga · Jun 1, 2022
FDA launching website, app for registration of cannabis, hemp cultivation The Food and Drug Administration is launching a phone app and a website for people to register their cultivation of cannabis and hemp plants, which are being removed from the category 5 narcotics list, FDA deputy secretary-general Withid Sariddeechaikool said on Wednesday. Bangkok Post · Jun 1, 2022
Zero Cost, FDA CGMP Approved LSD For Qualified Researchers, Provided By Ceruvia Lifesciences Ceruvia Lifesciences, a biopharmaceutical company, announced that it has produced the world's first LSD that meets stringent "Current Good Manufacturing Practices" (CGMP) standards required by the FDA for new drug approvals and is offering to supply it at no cost to qualified researchers. Benzinga · May 31, 2022
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog Cybin Inc. (CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics," has submitted an Investigational New Drug (or “IND”) application to the FDA. Benzinga · May 31, 2022
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month, bringing the total for the year to 15. This compares to the 24 NMEs the Food and… Benzinga · May 31, 2022
Hepatitis A Outbreak Linked To Organic Strawberries: What You Need To Know The U.S. and Canadian governments have traced recent outbreaks of hepatitis A infections to organic strawberries sold at major supermarket chains. Benzinga · May 31, 2022
Delta-8 Cannabis Compound Is Legal, Says Federal Appeals Court Plus: Libertarian Party changes abortion and bigotry planks, the FDA's weird rejection of fluvoxamine for treating COVID-19, and more... Reason · May 31, 2022
5 Oncology Stocks Wall Street Predicts Will Rally 135% or More The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of quality oncology… StockNews.com · May 31, 2022
Hepatitis A outbreak in the US, Canada: What we know so far The virus is likely to have spread due to contaminated organic strawberries sold between March 5 and April 25. Al Jazeera · May 31, 2022
FDA’s plan to ban menthol cigarettes is overdue Other countries, including Canada and countries in the European Union, have already taken this potentially live-saving step to take a more addictive product off the market. Chicago Sun-Times · May 31, 2022
US, Canadian regulators tie hepatitis cases to strawberries U.S. and Canadian regulators are investigating a hepatitis outbreak that may be linked to fresh organic strawberries The Independent UK · May 30, 2022
The FDA is investigating a hepatitis A outbreak potentially linked to strawberries The FDA is investigating a hepatitis A outbreak potentially linked to strawberries sold at a number of retailers, including Trader Joe's, Kroger, Safeway, Aldi and Walmart. WEKU · May 30, 2022
Reason · May 30, 2022 There's No Political Solution to the Baby Formula Shortage Governments can't plan economies, but can disrupt them.
Tribune News Service · May 30, 2022 Novavax missed its global moonshot but is angling to win over mRNA defectors Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its COVID-19 vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.
The Independent UK · May 30, 2022 Strawberries recalled from grocery stores across North America amid Hepatitis A outbreak Around 17 people have been infected and 12 hospitalised in US, while Canada has recorded 10 infections and four hospitalisations
The Guardian - AU · May 29, 2022 Australian company to ship baby formula to shortage-hit US Joe Biden welcomes ‘good news’ as Bubs Australia increases production and reassures local customers
WEKU · May 28, 2022 More baby formula shipments arrive from overseas in an effort to ease the shortage Australia is sending the equivalent of more than 27 million 8-ounce bottles of goat's milk and other baby formulas, as the U.S. government works to replenish store shelves during the shortage.
The Independent UK · May 28, 2022 Baby formula shortage will stretch on until late July, FDA chief says ‘My expectation is that within two months we should be beyond normal and with a plethora’
Benzinga · May 28, 2022 NOVN: First EPI Sales By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT
Benzinga · May 27, 2022 41 Stocks Moving In Friday's Mid-Day Session Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares rose 60.2% to $1.7136. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.
The Independent UK · May 27, 2022 NOT REAL NEWS: A look at what didn't happen this week Social media users shared a range of false claims this week
Benzinga · May 27, 2022 Revive Therapeutics: Positive Comments From The FDA Regarding Primary Endpoint Change The outlook for Revive Therapeutics Ltd. (OTC: RVVTF) Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19 got a little brighter on Thursday.
Reason · May 27, 2022 The FDA Completely Botched Its Response to the Baby Formula Shortage Plus: Resurrecting an extinct tiger, reviewing the police response to the Uvalde shooting, and more...